Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PCV13 booster immunogenicity in children primed with PCV10 versus PCV13
2012-005366-35Phase 3Completed
- Sponsor
- Biovomed
- Start
- Dec 2012
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of pneumococcal 13-valent conjugate vaccine in pneumococcal disease, sponsored by Biovomed. Started Dec 2012; status: completed.
02
Drugs
pneumococcal 13-valent conjugate vaccine
03
Conditions
pneumococcal disease
Beyond the preview
Go deeper on 2012-005366-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-005366-35.